USASOC Veterinary Pharmaceuticals

This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a separate written solicitation will not be issued. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2023-02 (February 14, 2023).

The 905th Contracting Office – intends to solicit, negotiate, and award a Single-Award Purchase Order for USASOC Veterinary Pharmaceuticals in support of the Special Forces animal training and mission requirements. Delivery will be no later than August 1, 2024. Clauses and provisions throughout this solicitation can be viewed by accessing website https://www.acquisition.gov.

FAR provision 52.212-1 [Instructions to Offerors Commercial] applies to this acquisition to include the following addenda: All offerors are cautioned that if selected for award, they must be registered in the System for Award Management (SAM). The SAM can be accessed via the internet at www.sam.gov or https://procurement.army.mil/bot. Confirmation of SAM registration will be validated prior to awarding a contract.

The provision at FAR 52.212-2, Evaluation – Commercial Items and any addendums to this provision apply to this acquisition. The clause at FAR 52.212-5, Contract Terms and Conditions to Implement Statutes or Executive Orders – Commercial Items applies to this acquisition. Vendors shall include a completed copy of FAR provision 52.212-3 Alt 1, Offeror Representations and Certifications with their offer. Offerors shall include a confirmation of receipt of any amendments to this solicitation. Failure to submit a confirmation could result in the offer being determined non- responsive.